“…Thus, treatments that block the upregulation of these adhesion molecules and reduce inflammatory processes have been shown in some studies to improve outcome in models of brain trauma (Chatizipantelli et al, 2002;Otto et al, 2002;Shohami et al, 1996). After brain injury, leukocyte and monocyte infiltration requires tethering on the surface of endothelial cells (Bevilacqua, 1993;Whalen et al, 1999) followed by the interaction of endothelial cell-adhesion molecules with integrins on the PMNL or monocyte surface (Clark et al, 1996;Mabon et al, 2000;Neish et al, 1995;Shanley et al, 1998) facilitating leukocyte extravasation through the BBB. To prevent this interaction, previous studies in spinal cord injury (SCI) have utilized a monoclonal antibody (mAb) to the CD11d subunit of the CD11d/ CD18 integrin Van der Vieren et al, 1999) to improve outcome.…”